Immunophenotypic analysis of Waldenstrom's macroglobulinemia
- PMID: 12720134
- DOI: 10.1053/sonc.2003.50074
Immunophenotypic analysis of Waldenstrom's macroglobulinemia
Erratum in
- Semin Oncol. 2002 Jun;15(2):427
Abstract
Immunophenotyping has become an essential tool for diagnosis of hematological malignancies. By contrast, for diagnosis of Waldenstrom's macroglobulinemia (WM) immunophenotyping is used only occasionally. From 150 patients with a IgM monoclonal gammopathy we have selected 60 cases with (1) morphological lymphoplasmocytoid bone marrow (BM) infiltration (>20%); (2) IgM paraprotein (>10g/L); and (3) absence of features of other lymphoma types. Immunophenotypic analysis was based on the use of the triple or quadruple monoclonal antibody (MoAb) combinations. To increase the sensitivity of the analysis of antigen expression, selected CD19(+)CD20(+) B cells were targeted. We have also explored the antigenic characteristics of both the plasma cell (PC) and mast cell (MC) compartments present in the BM from 15 WM patients. Clonal WM lymphocytes were characterized by the constant expression of pan-B markers (CD19, CD20, CD22, CD24) together with sIg, predominantly kappa (5:1, kappa:lambda ratio). A high proportion of cases (75%) were positive for FMC7 and CD25, but in contrast to hairy cell leukemia (HCL), these lymphocytes were always negative for CD103 and CD11c. CD10 antigen was also absent in all WM patients and less than one fifth of patients were positive for CD5 and CD23, while CD27, CD45RA, and BCL-2 were present in most malignant cells. In two cases, the coexistence of two different clones of B lymphocytes was identified, and in eight additional cases, intraclonal phenotypic heterogeneity was observed. As far as PCs are concerned, in most patients (85%) the number of PCs was within the normal range (median, 0.36%). The antigenic profile of these PCs differed from that observed in normal and myelomatous PC (CD38(++)CD19(++/-)CD56(-)CD45(++)CD20(+)). In three cases, PCs showed aberrant expression for CD5, CD22, or FMC7. Finally, the number of mast cells was significantly higher (0.058 +/- 0.13) as compared to normal BM (0.019 +/- 0.02) (P <.01), although they were immunophenotypically normal (CD117(+)CD2(-)CD25(-)).
Copyright 2003 Elsevier Inc. All rights reserved.
Similar articles
-
Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.Semin Oncol. 2003 Apr;30(2):182-6. doi: 10.1053/sonc.2003.50073. Semin Oncol. 2003. PMID: 12720133
-
Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.Leukemia. 2002 Aug;16(8):1460-9. doi: 10.1038/sj.leu.2402584. Leukemia. 2002. PMID: 12145686
-
Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.Am J Clin Pathol. 2005 Sep;124(3):414-20. doi: 10.1309/3G1X-DX0D-VHBN-VKB4. Am J Clin Pathol. 2005. PMID: 16191510
-
B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.Semin Hematol. 1999 Apr;36(2):104-14. Semin Hematol. 1999. PMID: 10319379 Review.
-
Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.Semin Oncol. 2003 Apr;30(2):110-5. doi: 10.1053/sonc.2003.50082. Semin Oncol. 2003. PMID: 12720118 Review.
Cited by
-
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Risk Stratification, and Clinical Problems.Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024061. doi: 10.4084/MJHID.2024.061. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 38984103 Free PMC article. Review.
-
Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia.Int J Cancer. 2023 May 1;152(9):1947-1963. doi: 10.1002/ijc.34405. Epub 2022 Dec 30. Int J Cancer. 2023. PMID: 36533670 Free PMC article.
-
Phenotypic Profile of Waldenström Macroglobulinaemia B-Cells: Establishment of a Diagnosis Scoring System and Clinico-Biological Correlations.J Cell Mol Med. 2025 May;29(10):e70620. doi: 10.1111/jcmm.70620. J Cell Mol Med. 2025. PMID: 40407640 Free PMC article.
-
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.Leukemia. 2012 Sep;26(9):1908-75. doi: 10.1038/leu.2012.120. Epub 2012 May 3. Leukemia. 2012. PMID: 22552007 Free PMC article.
-
Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond.Ther Adv Hematol. 2022 Apr 29;13:20406207221093962. doi: 10.1177/20406207221093962. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35510210 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous